Glytec, an innovator in diabetes care management has announced three patent notices of allowance to its growing patent portfolio, affording further protection of the proprietary diabetes technologies associated with its eGlycemic Management System®. Glytec offers the only patented and FDA-cleared solution for glycemic management that encompasses insulin dosing decision support for:1. inpatient AND outpatient settings2. intravenous AND subcutaneous insulin therapies,3. adult AND pediatric
Read More